Compare MO & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MO | GSK |
|---|---|---|
| Founded | 1822 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.6B | 102.0B |
| IPO Year | N/A | N/A |
| Metric | MO | GSK |
|---|---|---|
| Price | $55.79 | $50.34 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $60.29 | N/A |
| AVG Volume (30 Days) | ★ 10.1M | 3.3M |
| Earning Date | 01-29-2026 | 02-04-2026 |
| Dividend Yield | ★ 7.58% | 3.34% |
| EPS Growth | N/A | ★ 118.57 |
| EPS | ★ 5.24 | 1.79 |
| Revenue | $20,166,000,000.00 | ★ $43,237,357,842.00 |
| Revenue This Year | $1.45 | $6.70 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | ★ $10.66 | $28.12 |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $50.08 | $31.72 |
| 52 Week High | $68.60 | $51.46 |
| Indicator | MO | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 34.64 | 63.52 |
| Support Level | $54.70 | $48.59 |
| Resistance Level | $57.91 | $51.46 |
| Average True Range (ATR) | 0.79 | 0.59 |
| MACD | -0.30 | 0.08 |
| Stochastic Oscillator | 23.84 | 64.56 |
Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev and a 41% stake in cannabis manufacturer Cronos. It also acquired vaping company Njoy Holdings in 2023 and operates a joint venture with Japan Tobacco in the heated tobacco category for the US.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.